ICR — Intelicare Holdings Income Statement
0.000.00%
Last trade - 00:00
- AU$2.60m
- AU$1.49m
- AU$1.51m
- 37
- 31
- 22
- 20
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.268 | 0.332 | 0.928 | 1.24 | 1.51 |
Cost of Revenue | |||||
Gross Profit | 0.268 | 0.08 | 0.799 | 0.999 | 1.26 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.766 | 2.87 | 5.28 | 5.18 | 4.48 |
Operating Profit | -0.498 | -2.54 | -4.35 | -3.93 | -2.97 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.5 | -2.55 | -4.36 | -3.93 | -3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.5 | -2.55 | -4.36 | -3.93 | -3 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.5 | -2.55 | -4.36 | -3.93 | -3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.5 | -2.55 | -4.36 | -3.93 | -3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.006 | -0.03 | -0.051 | -0.034 | -0.018 |
Dividends per Share |